| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |